SHL – UBS rates the stock as Upgrade to Neutral from Sell

By Broker News | More Articles by Broker News

Recent share price weakness has improved the value on offer in the stock and so UBS upgrades to a Neutral rating.

Earnings forecasts and price target are unchanged.

Sector: Health Care Equipment & Services.

Target price is $11.21.Current Price is $10.71. Difference: $0.50 – (brackets indicate current price is over target). If SHL meets the UBS target it will return approximately 4% (excluding dividends, fees and charges – negative figures indicate an expected loss).


Broker News

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →